Iteos Therapeutics Inc expected to post earnings of 10cents a share - Earnings Preview

iTeos Therapeutics

05/11/2022 03:26

* Iteos Therapeutics Inc  ITOS.OQ   ITOS.O  is expected
to show a
fall in quarterly revenue when it reports  results on November 8
(estimated). 
    * The Watertown Massachusetts-based  company is expected to
report
 a 59.7% decrease in revenue to $42.049 million from $104.27
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Iteos Therapeutics
Inc is
for earnings of 10 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Iteos
Therapeutics Inc is $49.5​, above​ its last closing price
of $18.72. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  1.13        1.20       0.15      Missed  -87.5
 Mar. 31 2022  0.79        0.80       1.82      Beat    128.9
 Dec. 31 2021  1.84        1.28       4.89      Beat    282.6​
 Sep. 30 2021  6.09        4.95       1.86      Missed  -62.4
 ​​Jun.        -0.45       -0.41      -0.75     Missed  -81.2
 30 2021                                                
 Mar. 31 2021  -0.48       -0.48      -0.39     Beat    18.4​
 Dec. 31 2020              -0.42      -0.43     Missed  -1.8
 Sep. 30 2020  -0.36       -0.36      -0.48     Missed  -31.9
 This summary was machine generated November 5 at 03:25 GMT.  All
figures in US dollars  unless otherwise stated